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Nitric oxide is the main physiologic ligand of soluble gua-
nylyl cyclase (sGC), a hemoprotein with high affinity for
NO. Purified sGC binds NO with an estimated picomolar
Kd for NO, which corresponds to only a few molecules of
NO per cell. The His105 residue of the β subunit is the
proximal ligand of the heme (His105-heme complex with
a 430 nm Soret band). Binding of NO to the sGC heme
forms a six coordinate (6C) complex (His105-heme-NO),
which is then converted into a five coordinate (5C) com-
plex (His105 and heme-NO) [1]. This transformation
coincides with several hundred fold activation of the
cyclase activity. The enzyme displays NO-concentration
dependence not only in the NO binding, but also in the
6C sGC-NO→5C sGC-NO complex conversion [1]. Previ-
ous studies showed that the sGC-NO complex obtained
under stoichiometric NO amounts is not fully activated,
while addition of GTP substrate or additional NO results
in a fully activated sGC [2].
In this current report we investigated the molecular basis
of this NO- and GTP-dependence of enzyme activation.
Stop-flow techniques were used to monitor the kinetics of
NO-sGC complex formation and its fate under stoichio-
metric and excess NO conditions or in the presence of
GTP. Under both stoichiometric and excess NO condi-
tions 6C His105-heme-NO complex (~420 nm Soret
band) is formed at a diffusion limited rate independently
of the presence or absence of GTP. Although in all tested
conditions the His105-heme-NO complex is converted
into five coordinate complex (free His105 and heme-NO
complex; 399 nm Soret band), the fate of this complex
depends on the amount of NO applied or the presence of
GTP substrate.
Under stoichiometric conditions, the heme-NO reverts
back to a 430 nm species with sub-second kinetics, pre-
sumably due to the loss of NO. The newly formed His105-
heme complex (sGC*) may rebind NO and forms a 5C
sGC-NO complex (399 nm species), but with much
slower kinetics (minutes vs. sub-millisecond kinetics for
intial sGC). This secondary sGC-NO* complex is, most
probably, the weakly activated sGC-NO complex
described previously [2]. However, even a two-fold molar
excess NO or the presence of GTP generates a 5C NO-
heme complex with no sign of NO loss.
Spectral properties of the sGC* state generated after the
loss of NO (430 nm Soret peak) indicate that the heme
moiety remains coordinated by a histidine residue. Differ-
ent NO-binding properties, however, suggest that signifi-
cant changes in the properties of the enzyme occurred. We
investigated whether a change of proximal ligands may
explain such transformation during the conversion of 5C
sGC-NO to sGC*. We substituted the βHis107 position,
which is conserved in all mammalian β1 subunits, to leu-
cine. Similar to wild type sGC mutant αβHis107→Leu
enzyme also contains heme with a Soret peak at 430 nm.
The mutant has different NO-binding kinetics, since it
forms a stable sGC-NO complex, which does not loose
NO even under sub-stoichiometric NO conditions.
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These data support the notion that an exchange of the
proximal hisitidyl ligand may occur at substoichometric
NO concentrations. Such proximal ligand exchange may
be essential for the discrimination between a random NO
molecule (inhaled NO, dietary nitrite) and the activating
NO signal (NOS-generated) and may be a process critical
for the deactivation of sGC.
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